Acceleron Pharma Inc Acquired by Merck & Co Inc Call Transcript
My name is [Roel Beamonte], and I will be your conference operator today. At this time, I would like to welcome everyone to Merck's announced acquisition of Acceleron conference call. (Operator Instructions) Thank you. I would now like to turn the call over to Mr. Peter Dannenbaum, VP Investor Relations. Sir, please go ahead.
Thank you, Roel, and good morning, everyone. Welcome to Merck's investor call highlighting today's announced acquisition of Acceleron. Our agenda this morning includes Rob Davis, Merck's Chief Executive Officer, who will lead off our presentation. Rob will be followed by Dr. Dean Lee, President of Merck Research Labs; Dr. Roy Baynes, Head of Global Clinical Development; Frank Clyburn, President of Human Health; Caroline Litchfield, Chief Financial Officer. Q&A will follow the presentation and Joerg Koglin cardiovascular therapeutic area head will be present.
Before we get started, we would like to remind you that some of the statements we make during today's call may be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
